2024-513365-39-00招募中2 期
A randomized, double-blind, placebo-controlled trial comparing the efficacy and tolerance of solriamfetol in patients affected with idiopathic hypersomnia. SOLR-IH
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Amelle ISSA
Scientific
Centre Hospitalier Universitaire De Montpellier
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Efficacy and safety study of DEB025/Alisporivir combined to standard therapy (Peg-IFN and Ribavirin) in chronic hepatitis C genotype 1 naïve patients.Chronic Hepatitis C genotype 1 treatment-naïve patientsMedDRA version: 14.0Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-022867-37-BEovartis Pharma Services AG1,040
Unknown
不适用
BKF6006PACTR201702001947398International Atomic Energy Agency (IAEA)200
招募中
1 期
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancernon-small cell lung cancerITMCTR2100004896Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
已完成
不适用
A clinical study to evaluate the acute and sub-chronic improvement of endothelial function inLI89034F2-supplemented overweight adults with slightly elevated blood pressureCTRI/2019/06/019925aila Nutraceuticals75
进行中（未招募）
不适用
A randomized, double-blind, placebo-controlled trial of the efficacy and safety of DEB025/Alisporivir in combination with standard of care in hepatitis C genotype 1 treatmentnaïve patientsEUCTR2010-022867-37-ITOVARTIS FARMA1,040